In This Issue:
Save the Date: SCAI 2013 Scientific Sessions in Orlando, May 8-11
Drawing record attendance and rave reviews, SCAI 2012 Scientific Sessions was IMPORTANT, INTENSE, INSPIRING, and a whole lot of FUN in Las Vegas.
Now is the time to start planning for SCAI 2013 Scientific Sessions taking place May 8-11 at the Peabody in Orlando, FL.
Organized by Program Co-Directors Kenneth Rosenfield, MD, FSCAI and Morton Kern, MD, FSCAI and CHD Program Co-Directors Thomas Fagan, MD, FSCAI and Matthew J. Gillespie, MD, FSCAI, SCAI 2013 is sure to be a can't-miss program.
See you in Orlando!
Back to Top
RSVP NOW: SCAI Transradial Series to Offer Advanced Content This Fall
Following strong demand for SCAI's 2011 Transradial Interventional Program (TRIP) series, the Society has announced that it will be offering advanced content in its 2012 TRIP series with stops in Chicago on September 8, 2012 and Houston on December 15, 2012.
Many past TRIP attendees tell us they have tremendous patient outcomes applying what they learned in SCAI's initial TRIP series and are ready to take their radial intervention knowledge to the next level by learning more advanced procedural techniques and best practices.
With that in mind TRIP Co-chairs Samir B. Pancholy, MD, FSCAI and Sunil V. Rao, MD, FSCAI have designed a comprehensive one-day program for interventional cardiologists, interventional cardiology fellows-in-training and other healthcare professionals (nurses, technologists, etc) that will build upon the basics taught during previous TRIP programs, but that is also applicable to those who’ve not previously attended.
Advanced Content Includes:
- Traversing difficult anatomy
- Difficult interventional substrates
- Transradial Peripheral intervention
- Nursing / tech symposium
- Case based education
- Structured simulator curriculum with one-on-one faculty interaction
TRIP Chicago on September 8: Additional Info & Registration
TRIP Houston on December 15: Additional Info & Registration
Back to Top
Ziyad Hijazi, MD, FSCAI Testifies Before FDA on ASD Closure Devices
Representing SCAI, Past Society President Ziyad Hijazi, MD, MPH, FSCAI testified on the safety of atrial septal defect closure devices before a FDA Circulatory Systems Device Advisory Panel meeting on May 24. Atrial septal defects represent 10% of congenital heart defects. While recognized as a relatively benign form of cardiac disease, ASD can eventually contribute to significant morbidity and mortality if left untreated.
The purpose of the meeting was:
- To discuss the safety and effectiveness of ASD closure devices in the overall context of this disease;
- To discuss whether additional measures should be taken to improve protection of the public health (e.g., additional study and/or data analyses, labeling changes); and
- To communicate to patients and physicians what is and is not known about device treatment options.
Read the Outcome of the Advisory Panel Deliberations
Back to Top
Miss the SCAI-QIT Webinar on New Cath Lab Standards? View it Now!
Attracting nearly 250 attendees, yesterday's SCAI-QIT webinar, "What the Cath Lab Standards Update Has to Offer to Quality Improvement" was a huge success.
If you missed the webinar, the archived recording of it is now available online at http://webinars.scai.org/session.php?id=8969
Here's what some attendees had to say about the webinar:
"Excellent webinar- likes the links provided also - easier to access when content fresh in mind- thank you!"
"Excellent source of useful information, Thank You!"
"Very Informative and put together very well"
"Great webinar and recap of the Cath Lab Standards update. Look forward to sharing this information and implementing more Quality Improvement components."
Stay tuned as SCAI will soon be announcing a date for its next SCAI-QIT webinar on the new Appropriate Use Criteria (AUC) for Diagnostic Catheterization.
View the Recording of Yesterday's Webinar
Are You Committed to Quality? Then Enlist to be a SCAI-QIT Champion Now!
Access the Archive of Past SCAI-QIT Webinars
Back to Top
Visit SCAI's eLearning Library for Variety of Online Education Programs
SCAI is proud to offer a growing collection of online educational programs as a complement to our live meetings and courses. Ranging from courses to webinars, eLearning provides a number of benefits to interventional cardiologists, fellows-in-training, and other physicians and professionals with an interest in invasive and interventional cardiology.
Easy-to-Access Courses on Your Schedule: Physicians have access to all of our eLearning programs 24 hours a day, seven days a week. Continuous access means physicians have full control over their learning experience course material can be reviewed at the office or at home at a convenient time.
Cost-Effective CME Opportunities: Many of SCAI's eLearning programs offer CME credit for a fraction of the cost of live meetings, making it an economical solution for physicians seeking CME credit without travel and time out of the lab.
High-Quality Education: SCAI's eLearning programs feature content developed by some of interventional cardiology's leading experts. Each course connects you to basic and advanced information on a wide range of topics, and with teaching tools including narrated presentations, pre- and post-tests, and case studies, it has never been easier or faster to learn from the Best of the Best.
Visit SCAI's eLearning Library
Back to Top
June 30, 2012 is the Deadline for Avoiding the eRx Penalty in 2013
There is just one month left to avoid the 2013 e-prescribing (eRx) penalty. Under the Medicare Improvements for Patients and Providers Act of 2007 (MIPPA), health care providers who have not demonstrated successful e-prescribing by June 30, 2012, will have all their 2013 Medicare payments reduced by 1.5 percent.
According to CMS, individual eligible professionals and group practices can avoid the penalty by meeting the following six-month reporting requirements between now and the end of June:
- Individual eligible professionals: 10 e-prescribing events via claims;
- Small e-prescribing group using the group practice reporting option (GPRO): 625 e-prescribing events via claim; and
- Large e-prescribing group using the GPRO: 2,500 e-prescribing events via claims.
Back to Top
Reminder: Weigh In on NHLBI's PVD Research Priorities ASAP
SCAI's Peripheral Vascular Disease (PVD) Committee Chair Michael Jaff, DO, FSCAI is urging SCAI members to weigh in on research priorities in PVD with the National Heart, Lung and Blood Institute (NHLBI).
All feedback will be incorporated into the discussions of the NHLBI-sponsored Working Group entitled "Research Priorities and Challenges in Surgical and Endovascular Treatment of Peripheral Vascular Disease" to be held June 5, 2012 in advance of the 2012 Annual Meeting of the Society for Vascular Surgery. Gary Ansel, MD, FSCAI will be representing SCAI in this working group.
The working group would like your input on the following questions:
- What are the three most clinically important, unanswered research questions in the surgical and/or endovascular treatment of PVD?
- What are the top challenges likely to be encountered in PVD trials, particularly those involving vascular therapy and/or endovascular therapy? How can experience from other interventional trials inform us?
- What are the main challenges to successfully engaging in PVD research (basic, translational, and clinical)?
To respond, please send your comments to NHLBI_VSWG@mail.nih.gov
Back to Top
Society Asks CMS to Delay Integrated Care for Dual Eligible Individuals
Last week SCAI and its partners in the Alliance of Specialty Medicine asked the Centers for Medicare & Medicaid Services (CMS) to delay the implementation of its dual integration demonstrations for at least a year because of potential adverse effects it could have on access to specialty care for the dual-beneficiary population.
CMS' new initiative funded by the Affordable Care Act will provide 15 states with up to $1 million each to develop new ways to meet the complex and costly medical needs of individuals eligible for both the Medicare and Medicaid programs, known as "dual eligibles." While the goal of the program is to eliminate duplication of services for these patients, expand access and lower costs to this vulnerable population, we are deeply concerned about unintended consequences that are likely to impede on the initiative's stated aim.
Read SCAI's Letter to CMS Urging a Delay to this Initiative
Back to Top